Sleep Disorders in Pediatric Dialysis

Status Completed

Clinical Trial Summary

Sleep disorders (SD) are common in adults with Chronic Kidney Disease (CKD) on dialysis with a reported prevalence of 60-80%. To date three studies have reported on SDs in children with CKD but these have all been based on questionnaire data alone. The findings were not confirmed with polysomnograms (PSG), the gold standard to diagnose SD, or actigraphy, a validated tool to assess the sleep/ wake cycle over a prolonged period in the home. This is highly relevant given the poor sensitivity and specificity of even validated questionnaires alone. The effect of untreated pediatric SD is pervasive. This study will provide the first objective assessment of SDs using PSGs in children with severe CKD, both on and off dialysis. Therefore, we will recognize and when possible treat SD in this severe CKD cohort potentially contributing to their immediate management (eg improved control of hypertension, improved school performance), while improving their Quality of Life (QOL) and helping ensure they achieve their full potential.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01667588
Study type	Observational
Source	The Hospital for Sick Children
Contact
Status	Completed
Phase	N/A
Start date	August 2012
Completion date	March 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05422755` - The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients
Completed	`NCT01693029` - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa	Phase 3
Recruiting	`NCT04064827` - A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)	Phase 3
Completed	`NCT02218099` - A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease	Phase 1/Phase 2
Completed	`NCT02276742` - Lifestyle Management of CKD in Obese Diabetic Patients	N/A
Completed	`NCT01222234` - Impact of Vitamin D Therapies on Chronic Kidney Disease	N/A
Recruiting	`NCT05106387` - An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive A Kidney Transplant
Completed	`NCT05373303` - The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®	N/A
Completed	`NCT01247311` - Vitamin D and the Health of Blood Vessels in Kidney Disease	N/A
Completed	`NCT04042350` - Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on Dialysis
Completed	`NCT02733328` - Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
Completed	`NCT02341664` - Patient and Provider Assessment of Lipid Management Registry
Enrolling by invitation	`NCT06322641` - A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
Completed	`NCT05755373` - A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists
Completed	`NCT02678000` - Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function	Phase 2
Completed	`NCT02185911` - Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis	N/A
Terminated	`NCT03226899` - A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment	Phase 4
Completed	`NCT02504294` - A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis	Phase 3
Active, not recruiting	`NCT04094831` - Community-based Screening of Chronic Kidney Disease (CKD) and Measure the Impact of Health Education	N/A
Completed	`NCT01810939` - A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)	Phase 3